샘플 요청 목록

 카트 문의
시장보고서
상품코드
1405904

실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 규모, 점유율 및 동향 분석 보고서 : 기술별, 제품별, 용도별, 지역별, 부문별 동향(2024-2030년)

Real-time PCR, Digital PCR, And End-point PCR Market Size, Share & Trends Analysis Report By Technology (Quantitative, Digital, End-point), By Product, By Application, By Region, And Segment Forecasts, 2024 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장의 성장 및 동향 :

Grand View Research, Inc의 최신 보고서에 따르면 전 세계 실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 규모는 2024년부터 2030년까지 4.2%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 71억 8,000만 달러에 달할 것으로 예상됩니다.

그러나 코로나19 팬데믹의 영향을 제외한 실제 세계 실시간 PCR, 디지털 PCR, 엔드포인트 PCR 시장은 2023년부터 2030년까지 8.7%의 연평균 성장률(CAGR)로 확대될 것으로 예상됩니다. 디지털 PCR은 유사한 다수의 서열이 존재할 때 소수 서열을 절대적으로 정량화하고 분석하는 새로운 기술이며, dPCR은 정확하고 민감한 핵산 측정을 가능하게 합니다. 또한, 실시간 PCR은 질병의 정확한 조기 진단을 제공하여 신속하고 정확한 환자 치료를 제공합니다.

폐암, 혈액암, 뇌종양과 같은 질병 증가는 세계 시장에서의 적용 확대를 촉진하고 있으며, Globocan 2020에 따르면 폐암은 유럽에서 두 번째로 흔한 암으로 477,534건의 신규 진단을 받은 것으로 추산됩니다. 또한, 실시간 중합효소 연쇄반응 및 정량적 중합효소 연쇄반응과 같은 기존 기술에 비해 디지털 중합효소 연쇄반응의 장점은 예측 기간 동안 채택을 촉진할 것으로 보입니다. 또한, 신흥국의 의료비 지출 증가와 정확한 분자 질환 검출에 대한 요구가 증가하면서 시장 성장을 가속하고 있습니다.

또한, 코로나19의 대유행으로 인해 디지털 PCR 장비와 시약에 대한 수요가 증가하고 있으며, 코로나19 감염은 최신 디지털 PCR 장비를 통해 분자진단 기술로 검출되고 있습니다. 확진자가 발생했고, 약 530만 명이 사망한 것으로 집계됐습니다. 또한 제약 업계에서는 디지털 PCR 장비가 연구개발에도 활용되고 있습니다.

또한, 기술 발전과 세계 시장에서의 제품 출시 증가는 시장 성장을 뒷받침할 것으로 예상됩니다. 예를 들어, 2021년 6월 Bio-Rad Laboratories, Inc.는 코로나19 폐수 검사를 위한 PREvalence ddPCR SARS-CoV-2 폐수 정량 키트 출시를 발표했습니다.

또한, 기술 발전을 위한 R&D 프로젝트 증가와 디지털 중합효소 연쇄반응 개발을 위한 기업 간 협력 관계 증가는 PCR 검사의 활용을 증가시킬 것으로 예상됩니다. 예를 들어, 키아젠은 2022년 1월 Attila BioSystems &Actome GmbH와 제휴하여 비침습적 산전검사(NIPT) 기술을 QIAGEN의 dPCR에 제공함으로써 QIAcuity의 용도 수를 늘리고 있습니다. 그 결과, 실시간 PCR 및 디지털 PCR 기술의 사용은 예측 기간 동안 증가할 것으로 예상됩니다.

실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 보고서의 주요 내용:

  • 기술별로는 정량적 PCR 부문이 2023년 83.34% 이상의 가장 큰 매출 점유율을 차지했습니다. 이는 코로나19 선별 및 진단을 위한 실시간 중합효소 연쇄반응을 기반으로 한 제품 도입 지원 기술의 높은 채택에 기인합니다.
  • 소모품 및 시약 부문은 조기 발견에 대한 수요 증가와 디지털 PCR 소모품 및 시약을 제조하는 주요 기업의 수로 인해 2023년 62.62% 이상의 가장 큰 매출 점유율을 차지했습니다.
  • 북미는 높은 R&D 투자의 존재, 기술적으로 진보된 헬스케어 연구 프레임워크의 가용성, 저명한 중합효소 연쇄반응 제조업체의 강력한 존재, 이 지역의 신속한 진단 테스트에 대한 수요 증가로 인해 2023년 35.94% 이상의 매출 점유율을 차지하며 시장을 장악할 것으로 예상됩니다.

    목차

    제1장 조사 방법과 범위

    제2장 주요 요약

    제3장 실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 - 업계 전망

    • 시장 계통 전망
    • 시장 역학
    • 비교 해석
    • SWOT 분석, 요인별(정치·법률, 경제·기술)
    • 업계 분석 - Porter의 Five Forces 분석

    제4장 실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 분석, 기술 범위, 2018년-2030년

    • 실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 : 기술 변동 분석
    • 정량적
      • 정량적인 시장 추산·예측, 2018년-2030년
      • 소모품 및 시약
      • 기기
      • 소프트웨어 및 서비스
    • 디지털
      • 디지털 시장 추산·예측, 2018년-2030년
      • 소모품 및 시약
      • 기기
      • 소프트웨어 및 서비스
    • 엔드포인트 PCR
      • 엔드포인트 PCR 시장 추산·예측, 2018년-2030년
      • 소모품 및 시약
      • 기기
      • 소프트웨어 및 서비스

    제5장 실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 분석, 제품 범위, 2018년-2030년

    • 실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 : 제품 변동 분석
    • 소모품 및 시약
      • 소모품 및 시약 시장 추산·예측, 2018년-2030년
    • 기기
      • 기기 시장 추산·예측, 2018년-2030년
    • 소프트웨어 및 서비스
      • 소프트웨어 및 서비스 시장 추산·예측, 2018년-2030년

    제6장 실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 분석, 용도, 2018년-2030년

    • 실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 : 용도 변동 분석
    • 임상
      • 임상 시장 추산·예측, 2018년-2030년
      • 병원체 검사
      • 종양학 검사
      • 혈액검사
      • 액체 생검 검사
      • DPCR 기반 비침습적 산전 검사(Nipt)
      • 기타
    • 연구
      • 시장 추산·예측, 2018년-2030년을 조사
      • 줄기세포 조사
      • DNA 클로닝 및 배열 결정
      • 재조합 DNA 기술
      • 희귀 돌연변이 탐지
      • 유전자 발현
      • 단세포 분석
      • 마이크로바이옴 분석
      • 카피수 변화 분석
      • 라이브러리 정량화(NG)
      • mrna 및 mirna 발현
      • 종 식별
      • GMO 탐지
    • 법의학 및 기타

    제7장 실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 분석, 지역, 2018년-2030년

    • 국가별 시장 점유율 분석, 2023년 및 2030년
      • 북미
      • 유럽
      • 아시아태평양
      • 라틴아메리카
      • 중동 및 아프리카

    제8장 실시간 PCR(qPCR), 디지털 PCR(dPCR) 및 엔드포인트 PCR 시장 - 경쟁 구도

    • 기업 분류
    • 전략 매핑
      • 신제품 발매
      • 파트너십
      • 취득
      • 협업
      • 자금조달
    • 주요 기업의 시장 점유율 분석, 2023년
    • 기업 개요
      • Abbott
      • Qiagen
      • Bio-Rad Laboratories, Inc.
      • Agilent Technologies, Inc.
      • Thermo Fisher Scientific, Inc.
      • Ge Healthcare
      • Biomerieux Sa
      • F. Hoffmann-La Roche Ltd
      • Fluidigm Corporation
    LSH 24.01.26

    Real-time PCR, Digital PCR, And End-point PCR Market Growth & Trends:

    The global real-time PCR, digital PCR, and end-point PCR market size is expected to reach USD 7.18 billion by 2030, registering a CAGR of 4.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years

    The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.

    Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.

    Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.

    Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period.

    Real-time PCR, Digital PCR, And End-point PCR Market Report Highlights:

    • By technology, the Quantitative PCR segment held largest revenue share of over 83.34% in 2023. This is attributed to the high adoption of technology supported by the introduction of products based on real-time polymerase chain reaction for screening and diagnosis of COVID-19
    • The consumables and reagents segment held the largest revenue share of over 62.62% in 2023 due to the increased demand for earlier detection and the number of significant companies manufacturing digital PCR consumables and reagents
    • North America dominated the market with a revenue share of over 35.94% in 2023 due to the presence of high R&D investment, the availability of a technologically advanced healthcare research framework, the strong presence of prominent polymerase chain reaction manufacturers, and an expanding requirement for rapid diagnostic tests in the region

    Table of Contents

    Chapter 1 Methodology and Scope

    • 1.1 Market Segmentation
      • 1.1.1 Product Segment
      • 1.1.2 Technology Segment
      • 1.1.3 Application Segment
    • 1.2 Regional Scope
    • 1.3 Estimates And Forecast Timeline
    • 1.4 Objectives
      • 1.4.1 Objective - 1
      • 1.4.2 Objective - 2
      • 1.4.3 Objective - 3
    • 1.5 Research Methodology
    • 1.6 Information Procurement
      • 1.6.1 Purchased Database
      • 1.6.2 Gvr's Internal Database
      • 1.6.3 Secondary Sources
      • 1.6.4 Primary Research
    • 1.7 Information Or Data Analysis
      • 1.7.1 Data Analysis Models
    • 1.8 Market Formulation & Validation
    • 1.9 Model Details
      • 1.9.1 Commodity Flow Analysis
    • 1.10 List of Secondary Sources
    • 1.11 List of Abbreviations

    Chapter 2 Executive Summary

    • 2.1 Market Summary
    • 2.2 Segment Snapshot
    • 2.3 Competitive Landscape Snapshot

    Chapter 3 Real-time PCR (qPCR) Market - Industry Outlook

    • 3.1 Market Lineage Outlook
      • 3.1.1 Parent Market Lineage Outlook
      • 3.1.2 Related/Ancillary Market Outlook
    • 3.2 Market Dynamics
      • 3.2.1 Market Drivers
        • 3.2.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
        • 3.2.1.2 Technological advancements in PCR
        • 3.2.1.3 Implementation of MIQE guidelines
        • 3.2.1.4 Increasing demand for rapid diagnostic tests and growing adoption of qPCR & dPCR technologies
        • 3.2.1.5 Increasing number of CROs and forensic & research laboratories
        • 3.2.1.6 Increasing demand for prenatal genetic testing procedures
      • 3.2.2 Market Restraint Analysis
        • 3.2.2.1 High device costs associated with Real time PCR (qPCR)
        • 3.2.2.2 Stringent regulatory policies
    • 3.3 Comparative Analysis
    • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
    • 3.5 Industry Analysis - Porter's

    Chapter 4 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Technology Scope, 2018 - 2030 (Revenue, USD Million)

    • 4.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Technology Movement Analysis
    • 4.2 Quantitative
      • 4.2.1 Quantitative Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.2 Consumables & Reagents
        • 4.2.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.3 Instruments
        • 4.2.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.4 Software & Services
        • 4.2.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.3 Digital
      • 4.3.1 Digital Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.2 Consumables & Reagents
        • 4.3.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.3 Instruments
        • 4.3.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.3.4 Software & Services
        • 4.3.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.4 End-Point Pcr
      • 4.4.1 End-Point Pcr Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.2 Consumables & Reagents
        • 4.4.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.3 Instruments
        • 4.4.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.4.4 Software & Services
        • 4.4.4.1 Software & services market estimates and forecast, 2018 - 2030 (USD Million)

    Chapter 5 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Product Scope, 2018 - 2030 (Revenue, USD Million)

    • 5.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Products Movement Analysis
    • 5.2 Consumables & Reagents
      • 5.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3 Instruments
      • 5.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4 Software & Services
      • 5.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

    Chapter 6 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Application Scope, 2018 - 2030 (Revenue, USD Million)

    • 6.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Application Movement Analysis
    • 6.2 Clinical
      • 6.2.1 Clinical Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2 Pathogen Testing
        • 6.2.2.1 Pathogen Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.3 Oncology Testing
        • 6.2.3.1 Oncology Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.4 Blood Screening
        • 6.2.4.1 Blood Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.5 Liquid Biopsy Testing
        • 6.2.5.1 Liquid Biopsy Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.6 Dpcr-Based Non-Invasive Prenatal Testing (Nipt)
        • 6.2.6.1 Dpcr-Based Non-Invasive Prenatal Testing (Nipt) Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.7 Others
        • 6.2.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3 Research
      • 6.3.1 Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2 Stem Cell Research
        • 6.3.2.1 Stem Cell Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.3 Dna Cloning & Sequencing
        • 6.3.3.1 Dna Cloning & Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.4 Recombinant Dna Technology
        • 6.3.4.1 Recombinant Dna Technology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.5 Rare Mutation Detection
        • 6.3.5.1 Rare Mutation Detection Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.6 Gene Expression
        • 6.3.6.1 Gene Expression Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.7 Single-Cell Analysis
        • 6.3.7.1 Single-Cell Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.8 Microbiome Analysis
        • 6.3.8.1 Microbiome Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.9 Copy Number Variation Analysis
        • 6.3.9.1 Copy Number Variation Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.10 Library Quantification (Ngs)
        • 6.3.10.1 Library Quantification (Ngs) Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.11 Characterization Of Low-Fold Changes In Mrna And Mirna Expression
        • 6.3.11.1 Characterization Of Low-Fold Changes In Mrna And Mirna Expression Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.12 Species Identification
        • 6.3.12.1 Species identification market estimates and forecast, 2018 - 2030 (USD Million)
      • 6.3.13 GMO Detection
        • 6.3.13.1 GMO detection market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4 Forensics and Others
        • 6.4.1.1 Forensics and others market estimates and forecast, 2018 - 2030 (USD Million)

    Chapter 7 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Regional Scope, 2018 - 2030 (Revenue, USD Million)

    • 7.1 Market Share Analysis by Country, 2023 & 2030
      • 7.1.1 North America
        • 7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.1.2 U.S.
        • 7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.1.2.2 Key country dynamics
        • 7.1.1.2.3 Competitive scenario
        • 7.1.1.2.4 Regulatory framework
        • 7.1.1.3 Canada
        • 7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.1.3.2 Key country dynamics
        • 7.1.1.3.3 Competitive scenario
        • 7.1.1.3.4 Regulatory framework
      • 7.1.2 Europe
        • 7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.2.2 UK
        • 7.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.2.2.2 Key country dynamics
        • 7.1.2.2.3 Competitive scenario
        • 7.1.2.2.4 Regulatory framework
        • 7.1.2.3 Germany
        • 7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.2.3.2 Key country dynamics
        • 7.1.2.3.3 Competitive scenario
        • 7.1.2.3.4 Regulatory framework
        • 7.1.2.4 France
        • 7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.2.4.2 Key country dynamics
        • 7.1.2.4.3 Competitive scenario
        • 7.1.2.4.4 Regulatory framework
        • 7.1.2.5 Italy
        • 7.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.2.5.2 Key country dynamics
        • 7.1.2.5.3 Competitive scenario
        • 7.1.2.5.4 Regulatory framework
        • 7.1.2.6 Spain
        • 7.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.2.6.2 Key country dynamics
        • 7.1.2.6.3 Competitive scenario
        • 7.1.2.6.4 Regulatory framework
        • 7.1.2.7 Denmark
        • 7.1.2.7.1 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.2.7.2 Key country dynamics
        • 7.1.2.7.3 Competitive scenario
        • 7.1.2.7.4 Regulatory framework
        • 7.1.2.8 Sweden
        • 7.1.2.8.1 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.2.8.2 Key country dynamics
        • 7.1.2.8.3 Competitive scenario
        • 7.1.2.8.4 Regulatory framework
        • 7.1.2.9 Norway
        • 7.1.2.9.1 Norway market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.2.9.2 Key country dynamics
        • 7.1.2.9.3 Competitive scenario
        • 7.1.2.9.4 Regulatory framework
      • 7.1.3 Asia-Pacific
        • 7.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.3.2 Japan
        • 7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.3.2.2 Key country dynamics
        • 7.1.3.2.3 Competitive scenario
        • 7.1.3.2.4 Regulatory framework
        • 7.1.3.3 India
        • 7.1.3.3.1 India market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.3.3.2 Key country dynamics
        • 7.1.3.3.3 Competitive scenario
        • 7.1.3.3.4 Regulatory framework
        • 7.1.3.4 Australia
        • 7.1.3.4.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.3.4.2 Key country dynamics
        • 7.1.3.4.3 Competitive scenario
        • 7.1.3.4.4 Regulatory framework
        • 7.1.3.5 China
        • 7.1.3.5.1 China market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.3.5.2 Key country dynamics
        • 7.1.3.5.3 Competitive scenario
        • 7.1.3.5.4 Regulatory framework
        • 7.1.3.6 South Korea
        • 7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.3.6.2 Key country dynamics
        • 7.1.3.6.3 Competitive scenario
        • 7.1.3.6.4 Regulatory framework
        • 7.1.3.7 Thailand
        • 7.1.3.7.1 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.3.7.2 Key country dynamics
        • 7.1.3.7.3 Competitive scenario
        • 7.1.3.7.4 Regulatory framework
      • 7.1.4 Latin America
        • 7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.4.2 Brazil
        • 7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.4.2.2 Key country dynamics
        • 7.1.4.2.3 Competitive scenario
        • 7.1.4.2.4 Regulatory framework
        • 7.1.4.3 Mexico
        • 7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.4.3.2 Key country dynamics
        • 7.1.4.3.3 Competitive scenario
        • 7.1.4.3.4 Regulatory framework
        • 7.1.4.4 Argentina
        • 7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.4.4.2 Key country dynamics
        • 7.1.4.4.3 Competitive scenario
        • 7.1.4.4.4 Regulatory framework
      • 7.1.5 Middle East & Africa
        • 7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.5.2 South Africa
        • 7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.5.2.2 Key country dynamics
        • 7.1.5.2.3 Competitive scenario
        • 7.1.5.2.4 Regulatory framework
        • 7.1.5.3 Saudi Arabia
        • 7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.5.3.2 Key country dynamics
        • 7.1.5.3.3 Competitive scenario
        • 7.1.5.3.4 Regulatory framework
        • 7.1.5.4 UAE
        • 7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.5.4.2 Key country dynamics
        • 7.1.5.4.3 Competitive scenario
        • 7.1.5.4.4 Regulatory framework
        • 7.1.5.5 Kuwait
        • 7.1.5.5.1 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
        • 7.1.5.5.2 Key country dynamics
        • 7.1.5.5.3 Competitive scenario
        • 7.1.5.5.4 Regulatory framework

    Chapter 8 Real-time PCR (qPCR), end point PCR, and dPCR Market - Competitive Landscape

    • 8.1 Company Categorization
    • 8.2 Strategy Mapping
      • 8.2.1 New Product Launch
      • 8.2.2 Partnerships
      • 8.2.3 Acquisition
      • 8.2.4 Collaboration
      • 8.2.5 Funding
    • 8.3 Key Company Market Share Analysis, 2023
    • 8.4 Company Profiles
      • 8.4.1 Abbott
        • 8.4.1.1 Company Overview
        • 8.4.1.2 Financial Performance
        • 8.4.1.3 Product Benchmarking
        • 8.4.1.4 Strategic Initiatives
      • 8.4.2 Qiagen
        • 8.4.2.1 Company Overview
        • 8.4.2.2 Financial Performance
        • 8.4.2.3 Product Benchmarking
        • 8.4.2.4 Strategic Initiatives
      • 8.4.3 Bio-Rad Laboratories, Inc.
        • 8.4.3.1 Company Overview
        • 8.4.3.2 Financial Performance
        • 8.4.3.3 Product Benchmarking
        • 8.4.3.4 Strategic Initiatives
      • 8.4.4 Agilent Technologies, Inc.
        • 8.4.4.1 Company Overview
        • 8.4.4.2 Financial Performance
        • 8.4.4.3 Product Benchmarking
        • 8.4.4.4 Strategic Initiatives
      • 8.4.5 Thermo Fisher Scientific, Inc.
        • 8.4.5.1 Company Overview
        • 8.4.5.2 Affymetrix
        • 8.4.5.3 Company Overview
        • 8.4.5.4 Financial Performance
        • 8.4.5.5 Product Benchmarking
        • 8.4.5.6 Strategic Initiatives
      • 8.4.6 Ge Healthcare
        • 8.4.6.1 Company Overview
        • 8.4.6.2 Financial Performance
        • 8.4.6.3 Product Benchmarking
        • 8.4.6.4 Strategic Initiatives
      • 8.4.7 Biomerieux Sa
        • 8.4.7.1 Company Overview
        • 8.4.7.2 Financial Performance
        • 8.4.7.3 Product Benchmarking
        • 8.4.7.4 Strategic Initiatives
      • 8.4.8 F. Hoffmann-La Roche Ltd
        • 8.4.8.1 Company Overview
        • 8.4.8.2 Financial Performance
        • 8.4.8.3 Product Benchmarking
        • 8.4.8.4 Strategic Initiatives
      • 8.4.9 Fluidigm Corporation
        • 8.4.9.1 Company Overview
        • 8.4.9.2 Financial Performance
        • 8.4.9.3 Product Benchmarking
        • 8.4.9.4 Strategic Initiatives

    • 샘플 요청 목록
    0 건의 상품을 선택 중
    목록 보기
    전체삭제